Pilot Study of Metformin-induced CBP Phosphorylation at the Cellular Level and Corresponding Clinical Dose Response in Adults and Children
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Metformin (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Jun 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
- 03 Jul 2013 New trial record